1. Validation of the Simplified Magnetic Resonance Index of Activity [sMARIA] Without Gadolinium-enhanced Sequences for Crohn’s Disease
- Author
-
Victor Sapena, Nunzia Capozzi, Sonia Rodríguez, Ingrid Ordás, Jordi Rimola, Ignacio Alfaro, Julián Panés, Jesús Castro-Poceiro, Maria Carme Masamunt, Elena Ricart, and Agnès Fernández-Clotet
- Subjects
Adult ,Male ,medicine.medical_specialty ,Gadolinium ,chemistry.chemical_element ,Disease ,Severity of Illness Index ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Crohn Disease ,Internal medicine ,Outcome Assessment, Health Care ,Humans ,Medicine ,Derivation ,Inflammation ,Biological Products ,Crohn's disease ,medicine.diagnostic_test ,business.industry ,Patient Acuity ,Area under the curve ,Magnetic resonance imaging ,Colonoscopy ,General Medicine ,Gold standard (test) ,medicine.disease ,Magnetic Resonance Imaging ,Endoscopy ,Immunity, Active ,chemistry ,030220 oncology & carcinogenesis ,Female ,Tumor Necrosis Factor Inhibitors ,030211 gastroenterology & hepatology ,Immunotherapy ,business - Abstract
Background Gadolinium-enhanced sequences are not included in the simplified Magnetic Resonance Index of Activity [sMARIA], but in the derivation of this index readers had access to these sequences. The current study aimed to validate the sMARIA without gadolinium-enhanced sequences for assessing disease activity, severity, and response to treatment in patients with Crohn’s disease. Methods We prospectively included patients with active Crohn’s disease and at least one segment with severe inflammation [ulcers] at ileocolonoscopy, who required treatment with biologic drugs. Patients were evaluated by both magnetic resonance enterography [MRE] and ileocolonoscopy at baseline and 46 weeks after initiation of medical treatment. We compared the quantification of disease activity and response to treatment with sMARIA versus with ileocolonoscopy Crohn’s Disease Index of Severity [CDEIS], considered the gold standard. Results Data from both MRE and ileocolonoscopy 46 weeks after treatment initiation were available for 39 of the 50 patients. As in the derivation study, the optimal cutoffs were sMARIA ≥1 for predicting active disease (area under the curve [AUC] 0.92) and sMARIA ≥2 for predicting the presence of ulcers at ileocolonoscopy [AUC 0.93]. In evaluating the response to treatment, the sMARIA detected endoscopic ulcer healing at the segment level [sMARIA Conclusions The sMARIA is accurate and reliable in quantifying disease activity and response to treatment in luminal Crohn’s disease, without the need for gadolinium-enhanced sequences.
- Published
- 2020
- Full Text
- View/download PDF